Brief Biography:
Dr. Hossein Rezaeizadeh is a distinguished physician and scholar specializing in Traditional Persian Medicine. He currently serves as an Associate Professor at the School of Persian Medicine at Tehran University of Medical Sciences. With an extensive and illustrious career, Dr. Rezaeizadeh has held various leadership roles, contributing significantly to the advancement of Traditional Persian Medicine in both academia and industry.
Key Positions and Achievements:
- Dean, School of Persian Medicine, Tehran University of Medical Sciences (2014-2021)
- Member of the National Board of Traditional Medicine and Medical History of Iran (since 2017)
- Chairman of the Board of Traditional Medicine and Medical History of Iran (since 2018)
- Member of the Academy of Medical Sciences of the Islamic Republic of Iran (since 2010)
- Director, Incubator of Traditional Medicine & Natural Products
- Project Manager of the first innovation and acceleration center for Persian medicine and traditional pharmaceuticals (since 2019)
Academic and Professional Engagements:
- Founder, Chairman of the Board of Directors, and CEO of 7 companies with 11 years of research and development activities
- Vice President of the National Foundation of Persian Medicine (since 2017)
- Member of the Iranian Herbal Medicine Producers Association (since 2016)
- First alternate member of the Board of Directors of the Chamber of Commerce of Natural Products Producers of Iran (since 2021)
Research Interests:
- Complementary medicine, especially traditional Persian medicine
- Integrative Oncology (focus on the quality of life in cancer patients)
- Integrative Neurology (fields of multiple sclerosis and headaches)
Scientific Profile and Publications:
Dr. Rezaeizadeh has a notable scientific profile with contributions to various research areas. His work is published in reputable journals, and he has authored book chapters on natural anticancer drugs and integrative oncology. Additionally, he holds national patents for natural products addressing cancer-related fatigue and complications of radiation therapy.
National Patents:
- Honey Jell Daya – a natural product for cancer-related fatigue
- Modify Daya – a natural product for complications of radiation therapy in cancer
Research and Development Achievements:
Dr. Rezaeizadeh played a pivotal role in the development of Honey Jell Daya (Royal Jelly) and conducted clinical trials in collaboration with reputable radio-oncology centers in Iran. His research has been published in renowned journals, contributing valuable insights to cancer-related fatigue management.
Citations and Recognition:
His research on Royal Jelly has been cited in various publications, acknowledging the beneficial properties and synergistic effects with chemotherapeutic drugs.
Book Chapters:
Dr. Rezaeizadeh has contributed to book chapters on natural anticancer drugs and integrative oncology, showcasing his expertise in these fields.
Insurance and Licensing Information:
Dr. Hossein Rezaeizadeh is a licensed practitioner in Iran. Individuals seeking online consultation should note that insurance reimbursement is applicable only for residents of Iran.
For more details on Dr. Rezaeizadeh’s research and publications, you can visit the following links: